These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1389909)

  • 1. Biological response modifiers.
    Clark JW
    Cancer Chemother Biol Response Modif; 1992; 13():175-90. PubMed ID: 1389909
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological response modifiers: preclinical and clinical results.
    Talmadge JE; Clark J
    Cancer Chemother Biol Response Modif; 1987; 9():454-72. PubMed ID: 3079413
    [No Abstract]   [Full Text] [Related]  

  • 3. Biological response modifiers.
    Clark JW
    Cancer Chemother Biol Response Modif; 1988; 10():434-59. PubMed ID: 3079394
    [No Abstract]   [Full Text] [Related]  

  • 4. Biological response modifiers.
    Clark JW
    Cancer Chemother Biol Response Modif; 1990; 11():235-64. PubMed ID: 2121207
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunological monitoring and clinical trials of biological response modifiers.
    Kopp WC; Holmlund JT; Urba WJ
    Cancer Chemother Biol Response Modif; 1994; 15():226-86. PubMed ID: 7540029
    [No Abstract]   [Full Text] [Related]  

  • 6. [Disappointments and hopes in tumor therapy with biological response modifiers].
    Tanneberger S
    Z Arztl Fortbild (Jena); 1992 Jun; 86(11):551-8. PubMed ID: 1621399
    [No Abstract]   [Full Text] [Related]  

  • 7. Biological response modifiers.
    Clark JW
    Cancer Chemother Biol Response Modif; 1996; 16():239-73. PubMed ID: 8639384
    [No Abstract]   [Full Text] [Related]  

  • 8. Ex vivo and in vivo characterization of biological response modifiers (BRMs).
    Masihi KN; Talmadge JE
    Dev Biol Stand; 1992; 77():143-5. PubMed ID: 1426655
    [No Abstract]   [Full Text] [Related]  

  • 9. Biological response modifiers.
    Clark JW
    Cancer Chemother Biol Response Modif; 1993; 14():207-26. PubMed ID: 8312103
    [No Abstract]   [Full Text] [Related]  

  • 10. Nursing considerations for patients receiving biological response modifiers.
    Jassak PF
    Semin Oncol Nurs; 1993 Aug; 9(3 Suppl 1):32-5. PubMed ID: 8210793
    [No Abstract]   [Full Text] [Related]  

  • 11. Biological response modifiers.
    Clark JW
    Cancer Chemother Biol Response Modif; 1994; 15():190-212. PubMed ID: 7779586
    [No Abstract]   [Full Text] [Related]  

  • 12. [Elimination of minimal residual leukemic cells by biological response modifiers].
    Yamamoto K
    Rinsho Ketsueki; 1996 Aug; 37(8):666-70. PubMed ID: 8827875
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunological monitoring and clinical trials of biological response modifiers.
    Urba WJ; Baseler MW
    Cancer Chemother Biol Response Modif; 1990; 11():281-302. PubMed ID: 2121208
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunological monitoring and clinical trials of biological response modifiers.
    Baseler MW; Urba WJ
    Cancer Chemother Biol Response Modif; 1991; 12():231-50. PubMed ID: 1931445
    [No Abstract]   [Full Text] [Related]  

  • 15. [Tumoricidal biological response modifiers (BRM)].
    Niitsu Y; Kohgo Y; Watanabe N
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1407-13. PubMed ID: 1697152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic response modifiers in cancer therapy: a review.
    Quesada JR
    Tex Med; 1989 Nov; 85(11):42-7. PubMed ID: 2686076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of biological response modifiers in oncology].
    Vershinina SF; Potiavina EV
    Vopr Onkol; 2003; 49(2):145-51. PubMed ID: 12785193
    [No Abstract]   [Full Text] [Related]  

  • 18. Disillusionments and hopes in the field of biological response modifiers.
    Tanneberger S; Pannuti F
    Anticancer Res; 1993; 13(1):185-92. PubMed ID: 8476212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological response modifiers (BRM), chemotherapy, and activated cytotoxic leukocyte subsets: strategies for rational design of apheresis-based cancer immunotherapies.
    Stevenson HC; Klein HG
    Prog Clin Biol Res; 1990; 337():559-65. PubMed ID: 2353018
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current data on immunotherapy].
    Tigaud JM; Duarte A; Psyche S; Droz JP
    Rev Infirm; 1991 Dec; 41(19):30-1. PubMed ID: 1771342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.